Syndax Pharmaceuticals Inc. (SNDX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Syndax Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$14.32
+4.60% today
Market cap
$1.2B
Overall quality
—
Kronos AI 30-day
+39.7%
8 of 8 simulated paths end higher
Syndax Pharmaceuticals Inc. (SNDX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.2B. It trades at $14.32, up 4.60% today. 8 analysts' average target of $38.29 implies +167.4% from today's price. Kronos AI's 30-day forecast is +39.7% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $38.29 |
| Low – high | $23.00 – $57.00 |
| Analysts | 8 |
| Upside to average | +167.4% |
Kronos AI 30-day forecast
| Expected close | $19.12 (+39.7%) |
| Likely range | +29.6% … +44.8% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.